Parkinson Disease: Treatment Options Explained

Parkinson disease cannot yet be cured or reliably slowed, and it can be treated well. People diagnosed today can expect many years of good function with the right combination of medication, exercise and adjustments, and the difference between managing it well and managing it badly is substantial.

This guide covers what the treatments do, the decisions that have changed in recent years, the side effect that families need to know about before it causes damage, and the medications that must be avoided because they make everything worse.

🧠 What is happening

Parkinson disease involves the progressive loss of dopamine-producing neurons in a small region of the brain called the substantia nigra. Dopamine from there is essential for smooth, automatic, well-scaled movement, and as it falls, movement becomes slow, small and effortful.

By the time the classic motor symptoms appear, a substantial proportion of those neurons — commonly estimated at more than half — have already been lost. That is why the condition is well established at diagnosis and why treatments that replace dopamine work well early on: enough machinery remains to respond.

The three cardinal motor features are bradykinesia — slowness and reduction in the size of movement, which is required for the diagnosis — together with rigidity and rest tremor. Later, postural instability and balance problems develop.

Dopamine loss is not the whole disease. Other neurotransmitter systems are affected, and other brain regions are involved from early on, which is why many symptoms do not respond to dopamine replacement at all.

😴 The symptoms that come first

This is under-recognised and matters both for diagnosis and for quality of life, because non-motor symptoms frequently cause more disability than the movement problems do.

Several appear years or even decades before any tremor or slowness:

• Loss of sense of smell, often long before anything else and usually unnoticed
• Constipation, frequently severe and present for years beforehand
• Acting out dreams during sleep — shouting, punching, falling out of bed, with vivid dream recall. This is REM sleep behaviour disorder, and it is one of the strongest known predictors of later Parkinson disease or a related condition
• Depression and anxiety, which can precede motor symptoms by years
• Fatigue

Later non-motor features include drops in blood pressure on standing, urinary urgency, drooling, pain, sleep fragmentation, and cognitive change. Together these account for a large share of the burden of the condition, and they are frequently not asked about because appointments focus on movement.

💊 Levodopa

Levodopa remains the most effective treatment available for the motor symptoms, more than half a century after its introduction, and nothing has replaced it.

It works by being converted into dopamine in the brain. It is always given combined with a second drug — carbidopa or benserazide — which prevents that conversion happening in the body before it reaches the brain. Without that, most of the dose is wasted and nausea is severe. That is why carbidopa with levodopa is a single preparation rather than two decisions.

A significant change in practice deserves setting out clearly.

Levodopa used to be delayed. The reasoning was that its effectiveness declines over years and that starting late would preserve it for when it was most needed, so dopamine agonists were preferred first in younger patients.

That reasoning has not held up. Delaying levodopa does not preserve its later effect — the complications that develop relate to disease duration and progression rather than to how long the drug has been taken. Meanwhile trials comparing initial strategies found that people started on levodopa reported better quality of life and had fewer adverse effects than those started on dopamine agonists.

Current guidance in several countries therefore recommends levodopa first-line for most people whose motor symptoms are affecting their quality of life, with agonists and other classes reserved for specific situations or added later. Someone told to hold off starting treatment while symptoms interfere with their life is being given advice that has moved on.

📋 Taking levodopa properly

Several practical points determine how well it works, and most are not obvious.

Timing matters and it is not flexible. As the disease progresses, the window during which each dose works narrows, and taking it late produces a period of poor mobility that is entirely avoidable. Doses are taken to the clock rather than approximately.

Protein competes with absorption. Levodopa is an amino acid and uses the same transport system as dietary protein, both in the gut and at the blood-brain barrier. A protein-heavy meal can substantially blunt a dose. Taking it thirty to sixty minutes before food, or well after, avoids this. Where nausea makes that difficult, a small carbohydrate snack is a reasonable compromise. Some people benefit from redistributing protein toward the evening meal, which is a specialist adjustment rather than something to do independently.

Iron supplements bind it and should be separated by a couple of hours.

Nausea is common at first and usually settles. Where it persists, domperidone is used because it does not cross into the brain; metoclopramide and prochlorperazine must not be used, for reasons in the next section.

⏱️ Wearing off and dyskinesia

After some years on levodopa, two related problems typically emerge.

Wearing off means the benefit of each dose ends before the next is due, producing fluctuation between mobile periods and slow, stiff periods. Early signs are subtle — symptoms returning before the next dose, tremor reappearing in the late afternoon, or a period of anxiety or low mood at a predictable time, since non-motor symptoms fluctuate too.

Dyskinesia means involuntary writhing or fidgeting movements, usually occurring when levodopa levels are at their peak. It is frequently more distressing to families than to the person, many of whom prefer mild dyskinesia to being immobile.

Both are managed by adjusting the pattern rather than simply the total dose — smaller more frequent doses, adding a drug that extends levodopa duration, using controlled-release or dispersible forms, and in advanced disease by continuous delivery through a pump or by deep brain stimulation.

Keeping a diary for a week before an appointment — when doses were taken, when mobility was good, when it was poor, when involuntary movements occurred — is worth more than any description from memory and changes what can be adjusted.

⚠️ Dopamine agonists

Drugs such as pramipexole, ropinirole, rotigotine and piribedil stimulate dopamine receptors directly rather than being converted into dopamine.

They are less effective than levodopa for motor symptoms and produce fewer dyskinesias, which is why they were previously favoured early. They remain useful as an addition where levodopa alone is insufficient, and in specific circumstances.

Their adverse effects are the reason the balance has shifted:

🧪 The other drug classes

🚫 Medicines that must be avoided

This section is the most practically important in the article, because these drugs are prescribed in ordinary situations by people who do not have Parkinson disease in mind, and the consequences are immediate and severe.

Anything that blocks dopamine receptors will worsen Parkinson disease, sometimes dramatically and sometimes irreversibly in the short term.

Prochlorperazine given for dizziness and metoclopramide given for nausea are the two most frequent real-world offenders, and both are handed out routinely. Anyone with Parkinson disease should say so before accepting either, and it is worth carrying a written note of the diagnosis and current medication for exactly this situation.

🏃 Exercise

The evidence here is stronger than for anything else that is not a drug, and it is frequently mentioned in passing when it deserves emphasis.

Regular exercise improves motor function, balance, gait, mood and quality of life in Parkinson disease, and there is reasonable evidence that vigorous aerobic exercise may slow progression — something no medication has demonstrated.

What appears to matter:

• Intensity — more vigorous exercise shows greater benefit than gentle activity
• Amplitude — deliberately large, exaggerated movements counteract the shrinking of movement that characterises the disease, which is the principle behind specific Parkinson exercise programmes
• Balance and gait work — dance, boxing-based programmes, tai chi and Nordic walking all have supporting evidence and are more sustainable than gym work for many
• Consistency — benefit is lost when it stops
• Starting early rather than waiting for problems

Physiotherapy, occupational therapy and speech and language therapy are core rather than optional. Speech therapy in particular addresses the quiet, indistinct voice that develops and that people frequently do not notice in themselves, and specific intensive programmes have good evidence.

🔧 Advanced treatments

When medication alone cannot control fluctuations, several options exist and they are frequently offered later than they should be.

Deep brain stimulation involves electrodes placed in specific brain regions connected to a pulse generator. It substantially reduces fluctuations and dyskinesia in carefully selected people. The key selection points are that it works on symptoms that respond to levodopa — it does not help problems levodopa never helped — and that outcomes are better when it is considered before disability is advanced, rather than as a last resort.

Continuous infusion therapies deliver levodopa as a gel directly into the small intestine, or apomorphine under the skin, providing steady levels rather than the peaks and troughs of tablets.

Focused ultrasound is a newer option for tremor in selected patients.

🏠 The parts that are not medication

Falls become a leading cause of injury and hospital admission. Balance training, home hazard removal, appropriate footwear, medication review and treating postural blood pressure drops all reduce them, and falls prevention deserves as much attention as the tremor.

Constipation is nearly universal and frequently severe. It is worth treating properly rather than tolerating, and it also affects how reliably levodopa is absorbed.

Blood pressure dropping on standing causes dizziness and falls and is worsened by several of the medications. Measuring it lying and standing is a simple check that is often not done.

Swallowing deteriorates gradually and increases the risk of aspiration pneumonia, which is a leading cause of serious illness in advanced disease. Coughing during meals or a wet-sounding voice afterwards warrants speech therapy assessment.

Depression and anxiety are common, are part of the disease rather than only a reaction to it, and are treatable. Anxiety in particular can fluctuate with medication levels.

Sleep is disturbed for several overlapping reasons — difficulty turning in bed, night-time wearing off, restless legs, dream enactment, urinary frequency. Each has a different answer, so identifying which applies is worth doing rather than treating insomnia generically.

Cognitive change and hallucinations occur in a substantial proportion over time. Hallucinations frequently begin as a sense of a presence or fleeting movement in peripheral vision, and reviewing medication is the first step, since several Parkinson drugs contribute.

🔬 Can anything prevent or slow it

Honestly: nothing has been proven to slow progression, and claims otherwise should be treated with suspicion.

Regular vigorous exercise has the most encouraging evidence of anything, though it falls short of proof. Observational data associates coffee and smoking with lower risk, which is interesting biologically and not a recommendation. Various supplements have been trialled and none has demonstrated benefit.

The prevention advice in older versions of this article — avoiding head injury, staying fit, sleeping adequately, staying mentally active — is sensible general health guidance rather than established prevention for this specific condition, and it should not be presented as though following it prevents Parkinson disease.

🚨 When to seek help promptly

• New gambling, spending, sexual or eating behaviour that is out of character
• Hallucinations, confusion or paranoid beliefs
• Falling repeatedly, or any fall with injury
• Coughing during meals, or repeated chest infections
• Sudden marked worsening, which frequently indicates infection, a new medication or missed doses rather than disease progression
• Fever with rigidity and confusion, particularly after doses have been missed — emergency
• Falling asleep without warning, especially while driving
• Being prescribed metoclopramide, prochlorperazine or an antipsychotic by someone unaware of the diagnosis

Parkinson medication is stocked in the anti-Parkinsonian category, including Sinemet (carbidopa with levodopa), the cornerstone of treatment, alongside Mirapex, Eldepryl and Trivastal. Doses and timing require neurological supervision, and levodopa must never be stopped abruptly.

❓ Frequently asked questions

📑 Sources and editorial

• NICE guideline on Parkinson disease in adults
• PD MED and related trials comparing initial treatment strategies in Parkinson disease
• Movement Disorder Society evidence-based reviews of treatments for motor and non-motor symptoms
• Literature on impulse control disorders associated with dopamine agonist therapy
• Evidence on REM sleep behaviour disorder as a prodromal marker of synucleinopathies
• Trials of exercise intensity and disease progression in Parkinson disease
• Guidance on time-critical medication in hospital and on dopamine-blocking drugs to avoid
• FDA prescribing information for carbidopa-levodopa, pramipexole and selegiline
• Related products: anti-Parkinsonian category
• RXshop Editorial Team — reviewed by James Carter, MD, Neurology